.png)
.png)
.png)
Upload Prescription
.png)
1 Strip = 10 Tablets
Beacon Pharmaceuticals LtdProduct Description
Saroglitazar Magnesium is a novel, first-in-class dual peroxisome proliferator-activated receptor (PPAR) agonist, specifically targeting the α (alpha) and γ (gamma) subtypes. This unique mechanism allows it to function as a "glitazar," effectively addressing both lipid abnormalities and insulin resistance simultaneously. Activation of PPARalpha significantly reduces serum triglycerides and increases fatty acid oxidation, while its moderate PPARgamma agonism enhances insulin sensitivity and lowers blood glucose levels without the significant weight gain or edema often associated with full PPARgamma agonists like pioglitazone. Primarily indicated for the treatment of diabetic dyslipidemia and non-alcoholic steatohepatitis (NASH)—or more recently termed metabolic dysfunction-associated steatohepatitis (MASH)—it provides a comprehensive approach to cardiometabolic health. Clinical data highlights its ability to reduce non-HDL cholesterol and liver fat content, making it a critical therapeutic option for patients with complex metabolic syndrome who require both glycemic control and potent triglyceride management.
Similar Products
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
Previously Browsed Items
.jpg)
.jpg)
.png)
.jpg)
.jpg)
.jpg)
.jpg)
Copyright ﾃつｩ 2026 | Saf1 Rx | All rights reserved
.jpg)
.jpg)
.jfif)
